130 related articles for article (PubMed ID: 16393312)
1. Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus.
Vieth M; Kulig M; Leodolter A; Nauclér E; Jaspersen D; Labenz J; Meyer-Sabellek W; Lind T; Willich S; Malfertheiner P; Stolte M
Aliment Pharmacol Ther; 2006 Jan; 23(2):313-9. PubMed ID: 16393312
[TBL] [Abstract][Full Text] [Related]
2. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy.
Kiesslich R; Kanzler S; Vieth M; Moehler M; Neidig J; Thanka Nadar BJ; Schilling D; Burg J; Nafe B; Neurath MF; Galle PR
Dig Dis; 2004; 22(2):221-7. PubMed ID: 15383765
[TBL] [Abstract][Full Text] [Related]
3. What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?
Vieth M; Peitz U; Labenz J; Kulig M; Nauclér E; Jaspersen D; Meyer-Sabellek W; Willich S; Lind T; Malfertheiner P; Stolte M
Dig Dis; 2004; 22(2):196-201. PubMed ID: 15383761
[TBL] [Abstract][Full Text] [Related]
4. [Changes of intercellular spaces of esophageal epithelium in patients with gastroesophageal reflux disease before and after esomeprazole treatment].
Tao J; Xiao YL; Chen MH; Peng S; Lin JK; Xiong LS; Hu PJ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):392-5. PubMed ID: 17456380
[TBL] [Abstract][Full Text] [Related]
5. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
[TBL] [Abstract][Full Text] [Related]
6. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial.
Fiocca R; Mastracci L; Engström C; Attwood S; Ell C; Galmiche JP; Hatlebakk J; Junghard O; Lind T; Lundell L;
Am J Gastroenterol; 2010 May; 105(5):1015-23. PubMed ID: 19904246
[TBL] [Abstract][Full Text] [Related]
8. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
Sharma P; Johnson DA; Monyak JT; Illueca M
Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
[TBL] [Abstract][Full Text] [Related]
9. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
Malfertheiner P; Nocon M; Vieth M; Stolte M; Jaspersen D; Koelz HR; Labenz J; Leodolter A; Lind T; Richter K; Willich SN
Aliment Pharmacol Ther; 2012 Jan; 35(1):154-64. PubMed ID: 22070159
[TBL] [Abstract][Full Text] [Related]
10. Water load test before and after PPI therapy in patients with gastro-oesophageal reflux disease.
Battaglia E; Grassini M; Navino M; Niola P; Verna C; Mazzocchi A; Clerici C; Morelli A; Bassotti G
Dig Liver Dis; 2007 Dec; 39(12):1052-6. PubMed ID: 17913607
[TBL] [Abstract][Full Text] [Related]
11. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
[TBL] [Abstract][Full Text] [Related]
12. Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis.
Sjöstedt S; Befrits R; Sylvan A; Harthon C; Jörgensen L; Carling L; Modin S; Stubberöd A; Toth E; Lind T
Aliment Pharmacol Ther; 2005 Aug; 22(3):183-91. PubMed ID: 16091055
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
[TBL] [Abstract][Full Text] [Related]
14. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease.
Labenz J; Nocon M; Lind T; Leodolter A; Jaspersen D; Meyer-Sabellek W; Stolte M; Vieth M; Willich SN; Malfertheiner P
Am J Gastroenterol; 2006 Nov; 101(11):2457-62. PubMed ID: 17029609
[TBL] [Abstract][Full Text] [Related]
15. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
[TBL] [Abstract][Full Text] [Related]
16. Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms.
Tipnis NA; Rhee PL; Mittal RK
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G469-74. PubMed ID: 17556589
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus.
Stolte M; Vieth M; Schmitz JM; Alexandridis T; Seifert E
Scand J Gastroenterol; 2000 Nov; 35(11):1125-30. PubMed ID: 11145281
[TBL] [Abstract][Full Text] [Related]
18. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
[TBL] [Abstract][Full Text] [Related]
19. An open non-comparative clinical study for the evaluation of safety and efficacy of esomeprazole in patients of reflux oesophagitis in Indian population.
Dinakaran NH; Rajkumar JS; Potdar NP; Desai A
J Indian Med Assoc; 2002 Oct; 100(10):624-6. PubMed ID: 12452520
[TBL] [Abstract][Full Text] [Related]
20. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.
Gralnek IM; Dulai GS; Fennerty MB; Spiegel BM
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1452-8. PubMed ID: 17162239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
